( NASDAQ-SMALL:ROSG )

News from rosetta genomics ltd. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jun 13, 2013, 12:30 ET Medicare Administrator Issues Final Local Coverage Determination for Rosetta Cancer Origin Test™

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that Novitas...


Jun 06, 2013, 08:30 ET Rosetta Genomics Announces Acceptance for Publication by Molecular Cancer of Rosetta Cancer Origin Test Manuscript

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that a manuscript...


May 28, 2013, 08:30 ET Rosetta Genomics Announces Presence at ASCO 2013

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that the Company...


May 22, 2013, 08:30 ET Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that Kenneth A....


May 20, 2013, 08:30 ET Rosetta Genomics Announces Credentialing Agreement with Prime Health Services for miRview mets2

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that...


May 10, 2013, 08:30 ET Rosetta Genomics Receives Full Settlement Payment from Sanra Laboratories

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces receipt of $625,000...


May 07, 2013, 08:30 ET Rosetta Genomics microRNA-based Diagnostic Assays to be Showcased in an Industry Expert Theater Presentation at ASCO's 2013 Annual Meeting

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announces that the...


Apr 18, 2013, 09:00 ET Rosetta Genomics Reaches Settlement Agreement with Sanra Laboratories in Connection with Previous Sale of Parkway Clinical Laboratories

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that the...


Apr 02, 2013, 09:56 ET Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013

Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that two posters related...


Apr 01, 2013, 08:00 ET Rosetta Genomics Announces Acceptance for Publication of Kidney Cancer microRNA Diagnostic Manuscript by Molecular Oncology

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that a...


Mar 25, 2013, 08:30 ET Rosetta Genomics To Host Business Update Conference Call on April 10, 2013

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced...


Mar 18, 2013, 08:30 ET Rosetta Genomics Receives 25th U.S. Patent Allowance

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces receipt of a Notice...


Mar 12, 2013, 09:13 ET Rosetta Genomics to Present at the 25th Annual Roth Conference

Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that Ken Berlin,...


Feb 14, 2013, 08:30 ET Rosetta Genomics Receives Two Key U.S. Patent Allowances

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that the...


Feb 07, 2013, 09:00 ET Study Validating Ability of microRNAs to Predict Progression of Bladder Cancer Published in British Journal of Urology International

Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that data from a...


Jan 30, 2013, 09:42 ET Rosetta Genomics to be Featured on The Balancing Act® Airing on Lifetime Television Network

Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that the Company...


Jan 09, 2013, 08:30 ET Rosetta Genomics Reports Study Comparing microRNA Profiles of Cancer of Unknown Primary and Metastases of Known Primary Tumors Published in Clinical Experimental Metastasis

Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that data from a...


Jan 04, 2013, 08:30 ET Rosetta Genomics to Present at Sidoti & Company 2013 Micro-Cap Conference

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that Kenneth...


Nov 15, 2012, 09:15 ET Rosetta Genomics Added to Ocean Tomo 300 Patent Index

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced the...


Nov 08, 2012, 09:00 ET Rosetta Genomics to Appoint Dr. Yitzhak Peterburg to its Board of Directors

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced summoning of a...